BioRestorative Therapies
BRTX
16 hedge funds and large institutions have $1.11M invested in BioRestorative Therapies in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
23% more funds holding
Funds holding: 13 → 16 (+3)
19% more capital invested
Capital invested by funds: $932K → $1.11M (+$176K)
0.74% more ownership
Funds ownership: 8.67% → 9.41% (+0.74%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mariner
Overland Park,
Kansas
|
+$82.8K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.32K |
| 3 |
HGERS
Householder Group Estate & Retirement Specialist
Scottsdale,
Arizona
|
+$621 |
| 4 |
Wells Fargo
San Francisco,
California
|
+$9 |
| 5 |
AIM
Axiom Investment Management
New York
|
+$3 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$345 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $436K | – | – | – |
|
|
AC
2
Ayrton Capital
Westport,
Connecticut
| $198K | – | – | – |
|
|
WA
3
Wealth Alliance
Mellville,
New York
| $143K | – | – | – |
|
|
BFM
4
Boothbay Fund Management
New York
| $103K | – | – | – |
|
|
5
Mariner
Overland Park,
Kansas
| $86K | +$82.8K | +26,668 | New |
|
6
Cambridge Investment Research Advisors
Fairfield,
Iowa
| $74K | – | – | – |
|
7
Geode Capital Management
Boston,
Massachusetts
| $39K | – | – | – |
|
|
SPIA
8
Steward Partners Investment Advisory
New York
| $10K | – | – | – |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $7K | -$345 | -111 | -5% |
|
10
Osaic Holdings
Scottsdale,
Arizona
| $5K | – | – | – |
|
|
11
UBS Group
Zurich,
Switzerland
| $5K | +$3.32K | +1,068 | +214% |
|
|
IA
12
IFP Advisors
Tampa,
Florida
| $2K | – | – | – |
|
|
AIM
13
Axiom Investment Management
New York
| – | +$3 | +1 | New |
|
|
14
Wells Fargo
San Francisco,
California
| – | +$9 | +3 | +17% |
|
|
HGERS
15
Householder Group Estate & Retirement Specialist
Scottsdale,
Arizona
| – | +$621 | +200 | New |
|
BRTX Hedge Fund Activity: Q3 2022 in Review
16 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in BioRestorative Therapies (BRTX) for Q3 2022, worth a combined $1.11M — up 19% from $932K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new BRTX positions and 0 closed out — a net gain of 3 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Mariner, opening a new position worth an estimated $82.8K. The largest seller was Tower Research Capital (TRC), cutting an estimated $345.
- 16 institutional investors held BioRestorative Therapies (BRTX) as of Q3 2022, up from 13 in Q2 2022.
- Funds reported $1.11M of BioRestorative Therapies stock for Q3 2022, up 19% quarter-over-quarter.
- 3 funds opened new BioRestorative Therapies positions in Q3 2022 and 0 closed out, a net change of +3 holders.
- The largest BioRestorative Therapies buyer in Q3 2022 was Mariner, an estimated $82.8K added.
- The largest BioRestorative Therapies seller in Q3 2022 was Tower Research Capital (TRC), an estimated $345 sold.
Based on aggregated 13F filings for Q3 2022.